Lv43
546 积分 2025-01-23 加入
Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma
3小时前
待确认
Current developments in gastric cancer: from molecular profiling to treatment strategy
1天前
待确认
Gastric cancer
1天前
已关闭
Gastric cancer
1天前
已关闭
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Anlotinib in cancer therapy: mechanisms of action, clinical applications, and future perspectives
5天前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
23天前
已完结
Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2
28天前
已完结
Abstract CT010: Phase I dose-escalation and expansion study of JS107, a claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC), as monotherapy or in combination for patients (pts) with advanced solid tumors
1个月前
已关闭
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK -Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers
1个月前
已关闭
皖公网安备34019202002308
